NAD+ 1g & Retatrutide - A UK Update
The recent landscape of metabolic health in the UK is seeing significant interest in the combination of high-dose Nicotinamide Adenine Dinucleotide supplementation – often at 1g dosage – and the novel treatment Retatrutide (or its analogue Tirzepatide). Researchers are observing potential outcome